Late-stage funding of deployed, proven, promising external medical devices, technologies and therapies that are already helping patients. Ensuring that the devices, technologies or therapies can be prescribed by a physician and reimbursed by insurance.
Many inventions, devices and therapies are backed early by investors who believe a particular effort will improve the world we live in. Some are not even in it for the money at that early stage. Grants and donations flow to founders in the early years. But after years of hard work, stress and sleepless nights developing in the dark, they run out of runway while standing inches from full deployment. At that stage, many founders feel completely abandoned, and many give up. All of that effort, for nothing.
We fill that gap.
We do it for the patient: less pain, better mobility, more happiness, and a rapid improvement in quality of life, made accessible through insurance coverage.
We invest for equity participation, and we invest in people. We do not lend for repayment with interest. We fund the contract research organization (CRO), the clinical sites and the device inventory for the post-market studies (Phase IV / PMCF) that earn a dedicated HCPCS or CPT reimbursement code and favorable payer coverage. In return, we take an equity-linked position, typically a convertible note or redeemable convertible preferred, and a board seat. We attend two board meetings before we invest. The technology and the numbers are critical, but a team’s character is what we really invest in.
Conditions that affect pain, movement, eating, bathing, sleeping, anxiety and speech, and anything that speeds recovery or shortens a hospital stay. External medical devices (instrument, apparatus, equipment, prosthesis, hardware, wearable, tracker, monitor, sensor, peripheral, and similar), never inside the body.
Neurological & mobility. Parkinson’s, Multiple Sclerosis, Stroke, Shingles, partial paralysis, congenital malformation, essential tremor, spasticity, cognitive decline.
Joint & musculoskeletal, the common, everyday things. Bone spurs, rotator cuff, knee pain, ankle pain, carpal tunnel, tennis elbow, arthritis impeding dexterity, chronic low back pain and sciatica.
Head & nerve. Migraines, tinnitus, vertigo and balance disorders.
Comfort and tolerability during treatment. Radiation, immunotherapy, dialysis.
Autoimmune & metabolic. Lupus, lipedema, fluoroquinolone toxicity, diabetic peripheral neuropathy, lymphedema, sleep apnea, urinary incontinence.
Secondary area of interest. GSA contract, defense, diplomatic and technology applications; prisons and incarceration systems; and senior living. The same discipline applies: rigorous research, close assessment of the people behind the product, and a product that is already deployed.
Proven. Patented. FDA-cleared. Management that is knowledgeable, honest, visionary, dedicated, invested, and of solid character. A clean pre-money balance sheet. Executives who are humble and respectful. We root for the underdog, and the underdog wins.
Behind this are thirty years of building and operating companies: starting them, running them, turning them around, and structuring deals that would not have closed on their own.
If you invest in late-stage medical devices and want to compare diligence, or look at an opportunity alongside us, please feel free to contact us.